Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
$3.40 → $3.41 · observed estimates
TECNOGLASS HOLDINGS INC (TGLS)
NYSEMaterialsConstruction MaterialsSnapshot 2026-11-04
$42.81+8.05%
Close 2026-11-04 · 1-day change
NYSEMaterialsConstruction MaterialsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 6, 2026.
Next-FY EPS estimate change · 30 days
3.40 → 3.41 EPS · FY ending Dec 31, 2027 · 4 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 4 to 4; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for TGLS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain quarterly dividend of $0.15 | A supporting condition in TECNOGLASS HOLDINGS INC's published investment case. The stated target is $0.15. | Intact | dividend is cut or suspended | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
$3.40 → $3.41 · observed estimates
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
TGLS is a cyclical materials business with a sector tailwind, rather than a clear, steady compounder. The long-term thesis is intact this month, but execution is mixed and overall risk is elevated.
The valuation is cheap versus peers, and the expectations gap is modest, so the market does not appear to be assuming an especially strong improvement. Recent valuation readings fell materially, while the priced-in assessment describes the setup as justified with low fragility.
Revenue grew across the periods shown, but operating income fell from its 2025-Q3 level to 2026-Q2, leaving profitability progress limited. Management continues to emphasize revenue and profitability growth, while aluminum tariffs remain a stated concern whose financial effect is not quantified. Near term, sector strength may support results, but weakening employment could pressure this cyclical business.
The multi-year view partly hinges on whether management can turn revenue growth into stronger profitability and manage the impact of aluminum tariffs. Continued earnings strength and higher guidance from sector bellwethers would support the sector tailwind, while misses or lower guidance could weaken it. A continued slowdown in job growth would add recession risk for cyclical materials businesses.
Over the next 1 to 3 years, TGLS has a cheap-versus-peers valuation and an intact thesis, but mixed profitability and elevated cyclical risks keep the evidence balanced. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in TECNOGLASS HOLDINGS INC's published investment case. The stated target is >=36544000.0. |
| Under Pressure |
| falls below $36.5M in the next 4 quarters |
Operating income: $36.544M FY2026-Q2; GAAP. Published target: >=36544000.0. Target period is not explicitly aligned with this observation. Aug 6, 202636,544,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 6 of last 6 quarters. Revenue increased from $222.3M in 2025-Q1 to $295.3M in 2026-Q2, showing growth. However, operating income declined from $65.4M in 2025-Q3 to $36.5M in 2026-Q2, indicating mixed profitability trends. Management continues to emphasize revenue and profitability growth, but operating income trajectory shows limited progress. Delivery assessment Oct 31, 2026 |
Maintain revenue growth above $295.3M | A primary condition in TECNOGLASS HOLDINGS INC's published investment case. The stated target is >=295291000.0. | Under Pressure | falls below $295.3M in the next 4 quarters | Revenue: $295.291M FY2026-Q2; GAAP. Published target: >=295291000.0. Target period is not explicitly aligned with this observation. Aug 6, 2026295,291,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 6 of last 6 quarters. Revenue increased from $222.3M in 2025-Q1 to $295.3M in 2026-Q2, showing growth. However, operating income declined from $65.4M in 2025-Q3 to $36.5M in 2026-Q2, indicating mixed profitability trends. Management continues to emphasize revenue and profitability growth, but operating income trajectory shows limited progress. Delivery assessment Oct 31, 2026 |
Stored thesis · Oct 6, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.23B → $1.24B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-10-05 | $3.40 | $1,231,988,120 | 4 / 4 |
| 2026-10-06 | $3.40 | $1,231,988,120 | 4 / 4 |
| 2026-10-07 | $3.40 | $1,231,988,120 | 4 / 4 |
| 2026-10-08 | $3.40 | $1,231,988,120 | 4 / 4 |
| 2026-10-09 | $3.40 | $1,231,988,120 | 4 / 4 |
| 2026-10-10 | $3.40 | $1,231,988,120 | 4 / 4 |
| 2026-10-11 | $3.40 | $1,231,988,120 | 4 / 4 |
| 2026-10-12 | $3.40 | $1,231,988,120 | 4 / 4 |
| 2026-10-13 | $3.40 | $1,231,988,120 | 4 / 4 |
| 2026-10-14 | $3.40 | $1,231,988,120 | 4 / 4 |
| 2026-10-15 | $3.40 | $1,231,988,120 | 4 / 4 |
| 2026-10-16 | $3.40 | $1,231,988,120 | 4 / 4 |
| 2026-10-17 | $3.40 | $1,231,988,120 | 4 / 4 |
| 2026-10-18 | $3.40 | $1,231,988,120 | 4 / 4 |
| 2026-10-19 | $3.40 | $1,231,988,120 | 4 / 4 |
| 2026-10-20 | $3.40 | $1,231,988,120 | 4 / 4 |
| 2026-10-21 | $3.40 | $1,231,988,120 | 4 / 4 |
| 2026-10-22 | $3.41 | $1,236,988,120 | 4 / 4 |
| 2026-10-23 | $3.41 | $1,236,988,120 | 4 / 4 |
| 2026-10-24 | $3.41 | $1,236,988,120 | 4 / 4 |
| 2026-10-25 | $3.41 | $1,236,988,120 | 4 / 4 |
| 2026-10-26 | $3.41 | $1,236,988,120 | 4 / 4 |
| 2026-10-27 | $3.41 | $1,236,988,120 | 4 / 4 |
| 2026-10-28 | $3.41 | $1,236,988,120 | 4 / 4 |
| 2026-10-29 | $3.41 | $1,236,988,120 | 4 / 4 |
| 2026-10-30 | $3.41 | $1,236,988,120 | 4 / 4 |
| 2026-10-31 | $3.41 | $1,236,988,120 | 4 / 4 |
| 2026-11-01 | $3.41 | $1,236,988,120 | 4 / 4 |
| 2026-11-02 | $3.41 | $1,236,988,120 | 4 / 4 |
| 2026-11-03 | $3.41 | $1,236,988,120 | 4 / 4 |
| 2026-11-04 | $3.41 | $1,236,988,120 | 4 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 3 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.